Vascular-endothelial-growth-factor (VEGF) targeting therapies for endocrine refractory or resistant metastatic b... http://t.co/A3ao6CG9
Vascular-endothelial-growth-factor (VEGF) targeting therapies for endocrine refractory or resistant metastatic b... http://t.co/gOtOijCT
RT @CochraneLibrary: MT @cochranecollab: New #Cochrane Review: Treatments targeting blood vessels for metastatic breast cancer http://t.co/VEC9sgDA
RT @CochraneLibrary: MT @cochranecollab: New #Cochrane Review: Treatments targeting blood vessels for metastatic breast cancer http://t.co/VEC9sgDA
MT @cochranecollab: New #Cochrane Review: Treatments targeting blood vessels for metastatic breast cancer http://t.co/VEC9sgDA
RT @cochranecollab: New #Cochrane Review | Treatments targeting blood vessels for metastatic breast cancer | http://t.co/1EOC3RFv
RT @cochranecollab: New #Cochrane Review | Treatments targeting blood vessels for metastatic breast cancer | http://t.co/1EOC3RFv
RT @cochranecollab: New #Cochrane Review | Treatments targeting blood vessels for metastatic breast cancer | http://t.co/1EOC3RFv
New #Cochrane Review | Treatments targeting blood vessels for metastatic breast cancer | http://t.co/1EOC3RFv
Treatments targeting blood vessels for metastatic breast cancer ... http://t.co/9e2jcx4a
[VEGF] Vascular-endothelial-growth-factor (VEGF) targeting therapies for endocrine refractory or resistant me... http://t.co/8rKbgk8A PM
Avastin kann in Cochrane-Studie mit 4032 Brustkrebs-Patientinnen nicht überzeugen.Folgt die EMA nun der FDA 2011? (TL) http://t.co/WsjprVQQ